Damora Therapeutics, Inc. (DMRA) › Shareholders' EquityDamora Therapeutics, Inc. (DMRA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$33.84M2019: -$71.15M2020: $165.49M2021: $117.22M2022: $61.75M2023: $32.33M2024: $15.83M2025: $240.38M$240.38M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$240.38M+1418.4%2024$15.83M-51.0%2023$32.33M-47.6%2022$61.75M-47.3%2021$117.22M-29.2%2020$165.49M+332.6%2019-$71.15M-110.3%2018-$33.84M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share